Form 8-K - Current report:
SEC Accession No. 0001564590-21-035580
Filing Date
2021-07-02
Accepted
2021-07-02 08:01:05
Documents
12
Period of Report
2021-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kldo-8k_20210701.htm   iXBRL 8-K 38842
  Complete submission text file 0001564590-21-035580.txt   168952

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kldo-20210701.xsd EX-101.SCH 5772
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20210701_lab.xml EX-101.LAB 19650
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20210701_pre.xml EX-101.PRE 11626
5 EXTRACTED XBRL INSTANCE DOCUMENT kldo-8k_20210701_htm.xml XML 3539
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 211068017
SIC: 2836 Biological Products, (No Diagnostic Substances)